185 related articles for article (PubMed ID: 34468949)
21. Thyroid nodules with indeterminate cytology: prospective comparison between 18F-FDG-PET/CT, multiparametric neck ultrasonography, 99mTc-MIBI scintigraphy and histology.
Piccardo A; Puntoni M; Treglia G; Foppiani L; Bertagna F; Paparo F; Massollo M; Dib B; Paone G; Arlandini A; Catrambone U; Casazza S; Pastorino A; Cabria M; Giovanella L
Eur J Endocrinol; 2016 May; 174(5):693-703. PubMed ID: 26966173
[TBL] [Abstract][Full Text] [Related]
22. FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial.
de Koster EJ; Vriens D; van Aken MO; Dijkhorst-Oei LT; Oyen WJG; Peeters RP; Schepers A; de Geus-Oei LF; van den Hout WB;
Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3452-3469. PubMed ID: 35435497
[TBL] [Abstract][Full Text] [Related]
23. Dedicated neck
Trimboli P; Piccardo A; Alevizaki M; Virili C; Naseri M; Sola S; Paone G; Russ G; Giovanella L
Clin Endocrinol (Oxf); 2019 May; 90(5):737-743. PubMed ID: 30740757
[TBL] [Abstract][Full Text] [Related]
24. A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET.
Choi JS; Choi Y; Kim EK; Yoon JH; Youk JH; Han KH; Moon HJ; Kang WJ; Kwak JY
Ultraschall Med; 2014 Feb; 35(1):51-8. PubMed ID: 24458573
[TBL] [Abstract][Full Text] [Related]
25. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
[TBL] [Abstract][Full Text] [Related]
26. Comparison of 18F-FDG-PET and 18F-FDG-PET/CT for the diagnostic performance in thyroid nodules with indeterminate cytology: A meta-analysis.
Qichang W; Jinming S; Lu L; Bin J; Renjie W; Xiuying Z
Medicine (Baltimore); 2020 May; 99(22):e20446. PubMed ID: 32481449
[TBL] [Abstract][Full Text] [Related]
27. Role of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Evaluation of Cytologically Indeterminate Thyroid Nodules.
Buyukdereli G; Aktar Y; Kara E; Uguz A; Sonmez H
Iran J Radiol; 2016 Jan; 13(1):e21186. PubMed ID: 27110335
[TBL] [Abstract][Full Text] [Related]
28. Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.
Batawil N; Alkordy T
Eur J Surg Oncol; 2014 Feb; 40(2):182-6. PubMed ID: 24373298
[TBL] [Abstract][Full Text] [Related]
29.
Pattison DA; Bozin M; Gorelik A; Hofman MS; Hicks RJ; Skandarajah A
J Nucl Med; 2018 May; 59(5):749-755. PubMed ID: 29025986
[No Abstract] [Full Text] [Related]
30. Ultrasonography scoring systems can rule out malignancy in cytologically indeterminate thyroid nodules.
Grani G; Lamartina L; Ascoli V; Bosco D; Nardi F; D'Ambrosio F; Rubini A; Giacomelli L; Biffoni M; Filetti S; Durante C; Cantisani V
Endocrine; 2017 Aug; 57(2):256-261. PubMed ID: 27804016
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.
Demir Ö; Köse N; Özkan E; Ünlütürk U; Aras G; Erdoğan MF
Nucl Med Commun; 2016 Jul; 37(7):715-20. PubMed ID: 26963467
[TBL] [Abstract][Full Text] [Related]
32. The dilemma of
Scappaticcio L; Piccardo A; Treglia G; Poller DN; Trimboli P
Endocrine; 2021 Sep; 73(3):540-549. PubMed ID: 33761104
[TBL] [Abstract][Full Text] [Related]
33. Risk Stratification of
Felder GJ; Naeem M; Shady W; Shetty AS; Fraum TJ; Itani M
J Am Coll Radiol; 2021 Mar; 18(3 Pt A):388-394. PubMed ID: 33137296
[TBL] [Abstract][Full Text] [Related]
34. Fluorine-18-fluorodeoxyglucose positron emission tomography in thyroid nodules with indeterminate cytology: a prospective study.
Rosario PW; Rocha TG; Calsolari MR
Nucl Med Commun; 2019 Feb; 40(2):185-187. PubMed ID: 30444748
[TBL] [Abstract][Full Text] [Related]
35. Implications of US radiomics signature for predicting malignancy in thyroid nodules with indeterminate cytology.
Yoon J; Lee E; Kang SW; Han K; Park VY; Kwak JY
Eur Radiol; 2021 Jul; 31(7):5059-5067. PubMed ID: 33459858
[TBL] [Abstract][Full Text] [Related]
36. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
Kim TY; Kim WB; Ryu JS; Gong G; Hong SJ; Shong YK
Laryngoscope; 2005 Jun; 115(6):1074-8. PubMed ID: 15933524
[TBL] [Abstract][Full Text] [Related]
37. Thyroid Incidentalomas Detected on
Chung SR; Choi YJ; Suh CH; Kim HJ; Lee JJ; Kim WG; Sung TY; Lee YM; Song DE; Lee JH; Baek JH
Thyroid; 2018 Jun; 28(6):762-768. PubMed ID: 29759033
[TBL] [Abstract][Full Text] [Related]
38. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.
Choi JY; Lee KS; Kim HJ; Shim YM; Kwon OJ; Park K; Baek CH; Chung JH; Lee KH; Kim BT
J Nucl Med; 2006 Apr; 47(4):609-15. PubMed ID: 16595494
[TBL] [Abstract][Full Text] [Related]
39. Focal Thyroid Incidentalomas on
de Leijer JF; Metman MJH; van der Hoorn A; Brouwers AH; Kruijff S; van Hemel BM; Links TP; Westerlaan HE
Front Endocrinol (Lausanne); 2021; 12():723394. PubMed ID: 34744999
[TBL] [Abstract][Full Text] [Related]
40. Preoperative stratification of cytologically indeterminate thyroid nodules by [
Vriens D; de Koster EJ; de Geus-Oei LF; Oyen WJG;
Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):975-979. PubMed ID: 36658413
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
